Atlas Trials

S 81694 Plus Paclitaxel in Metastatic Breast Cancer

Clinical trial NCT03411161 · COMPLETED

Trial details

NCT number
NCT03411161
Sponsor
Institut de Recherches Internationales Servier
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Breast CancerMetastatic Triple Negative Breast Cancer
Start date
2018-01-04
Primary completion
2020-06-08
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.